Posts tagged with: "fda" Results 181 - 200 of 40,380
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
1 May 2024, 9:00 am by Staff
The post Understanding the Different Types of Nursing Jobs and Corresponding Compliance Issues – Part Two appeared first on Cohen Healthcare Law Group | Healthcare Lawyers | FDA & FTC Law. [read post]
1 May 2024, 8:37 am by Bill Marler
The CDC and FDA have reported that as of April 30, 2024, 12 people infected with E. coli have been reported from Washington and California. [read post]
1 May 2024, 3:00 am by Yosi Yahoudai
Olson believes it is just a matter of time before such drugs are approved as therapeutic medicines by the FDA. [read post]
30 Apr 2024, 7:39 pm by Bill Marler
The FDA determined that Gibson Farms, Inc of Hollister, California was the supplier of organic walnuts that were distributed to multiple natural food and co-op stores across the United States and sold in bulk bins. [read post]
30 Apr 2024, 7:05 pm by Bill Marler
The CDC and FDA have reported that as of April 30, 2024, 12 people infected with E. coli have been reported from Washington and California. [read post]
30 Apr 2024, 6:41 pm by Kurt R. Karst
  However, Table 1 states that if the SIR request is received within 60 days of the FDA “marketing submission letter” FDA would, resources permitting, have the meeting or provide written feedback within 21 days. [read post]
30 Apr 2024, 3:33 pm by Bill Marler
FDA has reason to believe that the following retail locations received the walnuts, included in the recall by Gibson Farms. [read post]
30 Apr 2024, 3:11 pm by News Desk
The FDA is working to determine what specific stores received the walnuts. [read post]
30 Apr 2024, 2:46 pm by Coral Beach
The FDA is working to determine what specific stores received the walnuts. [read post]
30 Apr 2024, 2:43 pm by Bill Marler
Traceback data collected by FDA determined that Gibson Farms, Inc was the supplier of organic walnuts sold in bulk bins at stores where ill people shopped. [read post]
30 Apr 2024, 11:52 am by Scharon Harding
Per the FTC, when Razer.com listed the Zephyr in 2021, it said that the mask offered "replaceable N95 Grade filters" and that Zephyr was "FDA-registered and lab-tested for 99 percent BFE [bacterial filtration efficiency]" and offered "greater protection compared to standard disposable/cloth masks, and filters air both inhaled and exhaled to safeguard you and others around you. [read post]
29 Apr 2024, 10:00 pm
FDA recently issued a revised draft guidance titled Promotional Labeling and Advertising Considerations for Prescription Biological Reference Products, Biosimilar Products, and Interchangeable Biosimilar Products . [read post]
29 Apr 2024, 10:00 pm
FDA recently issued a revised draft guidance titled Promotional Labeling and Advertising Considerations for Prescription Biological Reference Products, Biosimilar Products, and Interchangeable Biosimilar Products . [read post]
29 Apr 2024, 10:00 pm
FDA recently issued a revised draft guidance titled Promotional Labeling and Advertising Considerations for Prescription Biological Reference Products, Biosimilar Products, and Interchangeable Biosimilar Products . [read post]
29 Apr 2024, 10:00 pm
FDA recently issued a revised draft guidance titled Promotional Labeling and Advertising Considerations for Prescription Biological Reference Products, Biosimilar Products, and Interchangeable Biosimilar Products . [read post]
29 Apr 2024, 10:00 pm
FDA recently issued a revised draft guidance titled Promotional Labeling and Advertising Considerations for Prescription Biological Reference Products, Biosimilar Products, and Interchangeable Biosimilar Products . [read post]
29 Apr 2024, 10:00 pm
FDA recently issued a revised draft guidance titled Promotional Labeling and Advertising Considerations for Prescription Biological Reference Products, Biosimilar Products, and Interchangeable Biosimilar Products . [read post]
29 Apr 2024, 8:14 pm by Kurt R. Karst
This is the third letter from some of the same Democratic lawmakers to the Attorney General and DEA Administrator on marijuana rescheduling since the Food and Drug Administration (“FDA”) and Health and Human Services (“HHS”) recommended rescheduling in schedule III last August. [read post]
Since FDA issued its Proposed Rule (the “Proposed Rule”) in the Fall of 2023, Epstein Becker Green (EBG) and other industry stakeholders have eagerly awaited FDA’s issuance of the Final Rule and have speculated as ... [read post]
29 Apr 2024, 11:42 am by Yosi Yahoudai
” The FDA’s website warns patients that the risks of ingesting the sound-dampening foam could include headache, asthma, allergic reactions and more serious problems. [read post]